Norway Crocin Market Size & Outlook, 2023-2030
Norway crocin market, 2018-2030 (US$M)
Related Markets
Norway crocin market highlights
- The Norway crocin market generated a revenue of USD 50.2 million in 2023 and is expected to reach USD 70.0 million by 2030.
- The Norway market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
- In terms of segment, purity>98% was the largest revenue generating purity in 2023.
- Purity>98% is the most lucrative purity segment registering the fastest growth during the forecast period.
Crocin market data book summary
| Market revenue in 2023 | USD 50.2 million |
| Market revenue in 2030 | USD 70.0 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | Purity>98% |
| Fastest growing segment | Purity>98% |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Purity>98%, Purity<98% |
| Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
Other key industry trends
- In terms of revenue, Norway accounted for 1.0% of the global crocin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany crocin market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 264.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Crocin Market Scope
Crocin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway crocin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.22% in 2023. Horizon Databook has segmented the Norway crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing awareness about the use of paracetamol and prescription drugs for fever, headaches, body aches, & postoperative pain are expected to drive the Norway market. For instance, in 2021, around 26,900 coronary angiographies and 11,100 percutaneous coronary intervention procedures were performed in the country.
The increasing geriatric population is expected to further boost the overall number of surgical procedures in the country, creating opportunities for key stakeholders in the crocin market. According to World Bank data, in 2022, the overall population aged 65 years & above in Norway was around 1 million, which is expected to increase in the coming decade.
Companies are entering and expanding their reach into the Norway paracetamol market to capitalize on lucrative opportunities. Norway-based companies, such as Curida, Pharmasum Therapeutics, and Vistin Pharma, offer multiple dosages and forms of paracetamol for fever & pain associated with other diseases.
Reasons to subscribe to Norway crocin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway crocin market databook
-
Our clientele includes a mix of crocin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway crocin market , including forecasts for subscribers. This country databook contains high-level insights into Norway crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway crocin market size, by purity, 2018-2030 (US$M)
Norway Crocin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
